Skip to main content
REGN logo

REGN

Regeneron Pharmaceuticals, Inc.
$662.88 -13.35 (-1.97%) At close · Jul 8
Market Cap
$69.50B
Shares
104,839,032

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 1,398
Total Value: $68,693,761,909
Total Shares: 88,980,675
Showing 1–100 of 1,453 holdings by value · page 1 of 15

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 1,399 13F filers
Top Holder
10.1%
Jun 2023 → Mar 2026 · range 9.5% – 11.3%
of institutional value
Top 5
32.6%
Jun 2023 → Mar 2026 · range 32.6% – 42.8%
of institutional value
Top 10
45.6%
Jun 2023 → Mar 2026 · range 45.6% – 58.5%
of institutional value
HHI
305
Jun 2023 → Mar 2026 · range 305 – 459
Broadly held
Showing 100 of 1,453
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 872589 CUSIP 75886F107 13F (30d) 90 filings 47 filers Visit website Investor relations